1. PTU-126 Mortality Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease. (9th June 2014) Authors: Morgan, CL; Jenkins-Jones, S; Radwan, A; Conway, P; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTU-127 Resource Use Associated With Hepatic Encephalopathy In Patients With Severe Liver Disease. (9th June 2014) Authors: Orr, J; Morgan, CL; Hudson, M; Jenkins-Jones, S; Conway, P; Radwan, A; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-153 Cost Effectiveness Of Rifaximin-a In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy. (9th June 2014) Authors: Poole, CD; Conway, P; Nanuwa, K; Joseph, B; Bannister, C; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-154 The First Evaluation Of The Relationship Between The Chronic Liver Disease Questionnaire And The Eq-5d Index In Hepatic Encephalopathy Patients Treated With Rifaximin-a. (9th June 2014) Authors: Berni, E; Bannister, C; Poole, CD; Conway, P; Nanuwa, K; Currie, CJ Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗